CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
-2.22%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+0.55%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
509
New
13
Increased
172
Reduced
270
Closed
23
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Amazon
AMZN
|
$8.41M |
| 3 |
Microsoft
MSFT
|
$6.53M |
| 4 |
Analog Devices
ADI
|
$4.63M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$3.68M |
Top Sells
| 1 |
iShares Silver Trust
SLV
|
$7.9M |
| 2 |
ProShares Ultra Gold
UGL
|
$7.89M |
| 3 |
Arista Networks
ANET
|
$6.7M |
| 4 |
Gilead Sciences
GILD
|
$5.26M |
| 5 |
TSMC
TSM
|
$3.61M |
Sector Composition
| 1 | Technology | 36.93% |
| 2 | Healthcare | 24.36% |
| 3 | Consumer Discretionary | 11.82% |
| 4 | Communication Services | 11.17% |
| 5 | Consumer Staples | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Marriott International Class A Common Stock
MAR
$72B
| $1.62M | 0.15% |
6,809
+2,287
| +51% | +$545K |
|
|
TEM
127
Tempus AI, Inc. Class A Common Stock
TEM
$13.3B
| $1.62M | 0.15% |
33,531
+1,216
| +4% | +$58.7K |
|
128
PayPal
PYPL
$66.5B
| $1.59M | 0.15% |
24,433
+8,118
| +50% | +$530K |
|
129
Bank of America
BAC
$371B
| $1.59M | 0.15% |
38,071
+3,495
| +10% | +$146K |
|
130
Chevron
CVX
$318B
| $1.59M | 0.15% |
9,489
+887
| +10% | +$148K |
|
131
Halozyme
HALO
$8.75B
| $1.58M | 0.15% |
24,702
-2,275
| -8% | -$145K |
|
132
Roper Technologies
ROP
$56.4B
| $1.56M | 0.15% |
2,652
+907
| +52% | +$535K |
|
133
Zeta Global
ZETA
$4.47B
| $1.56M | 0.15% |
115,000
+80,000
| +229% | +$1.08M |
|
134
Constellation Energy
CEG
$96.4B
| $1.56M | 0.15% |
7,727
+2,637
| +52% | +$532K |
|
135
Vanguard World Funds Extended Duration ETF
EDV
$3.51B
| $1.54M | 0.14% |
21,612
-4,080
| -16% | -$290K |
|
136
Spotify
SPOT
$143B
| $1.51M | 0.14% |
+2,750
| New | +$1.51M |
|
137
Jazz Pharmaceuticals
JAZZ
$7.99B
| $1.51M | 0.14% |
12,182
-637
| -5% | -$79.1K |
|
138
Celestica
CLS
$24.4B
| $1.47M | 0.14% |
18,700
+10,200
| +120% | +$804K |
|
139
Madrigal Pharmaceuticals
MDGL
$9.7B
| $1.47M | 0.14% |
4,429
-196
| -4% | -$64.9K |
|
|
VRNA
140
Verona Pharma
VRNA
$9.18B
| $1.46M | 0.14% |
22,967
+119
| +0.5% | +$7.56K |
|
141
Roivant Sciences
ROIV
$8.6B
| $1.44M | 0.13% |
143,126
-11,226
| -7% | -$113K |
|
142
American Electric Power
AEP
$58.8B
| $1.44M | 0.13% |
13,170
+4,503
| +52% | +$492K |
|
143
DocuSign
DOCU
$15.3B
| $1.42M | 0.13% |
+17,500
| New | +$1.42M |
|
144
Monster Beverage
MNST
$62B
| $1.41M | 0.13% |
24,036
+8,209
| +52% | +$480K |
|
145
Novo Nordisk
NVO
$252B
| $1.4M | 0.13% |
20,000
| – | – |
|
146
Philip Morris
PM
$254B
| $1.38M | 0.13% |
8,642
+944
| +12% | +$151K |
|
147
CSX Corp
CSX
$60.2B
| $1.38M | 0.13% |
46,795
+15,412
| +49% | +$454K |
|
148
Paychex
PAYX
$48.8B
| $1.37M | 0.13% |
8,893
+3,036
| +52% | +$468K |
|
149
Copart
CPRT
$46.5B
| $1.35M | 0.13% |
23,862
+8,181
| +52% | +$463K |
|
150
BridgeBio Pharma
BBIO
$9.91B
| $1.32M | 0.12% |
38,149
-1,924
| -5% | -$66.5K |
|